A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
about
Vaccines for preventing malaria (SPf66)WITHDRAWN: Vaccines for preventing malaria.Vaccines for preventing malariaIMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine developmentMultispecies Plasmodium infections of humansNYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.Fever in patients with mixed-species malariaMalaria vaccine trials: the missing qualitative data.Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection.Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine.Recent advances in the development of a chemically synthesised anti-malarial vaccine.Serological responses of Gambian children to immunization with the malaria vaccine SPf66.Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.Safety evaluation of SPf66 malaria vaccine in Brazil.Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.Randomization and baseline transmission in vaccine field trials
P2860
Q21032526-B619E48C-880F-4349-862A-FBEC57C19812Q24244392-C95E6A49-96D5-4716-B1A7-177B5E54E27CQ24250252-DB4E66B4-3370-4609-8D63-1AA235E60503Q30373743-E895718F-40BE-4727-ABA2-465D6A591A53Q33596156-57D8044B-7A6A-472A-804D-2968EA4784E4Q35519418-17B971F0-D25B-4098-B351-4FBB25B72965Q35862464-16642543-548E-499F-899F-FF7367412B1EQ36787058-D4B27E6E-437E-48CA-825C-CC754F104755Q36827211-1288A382-3687-4291-B364-B705D579FC44Q37352530-14A41FAE-1FC3-41A3-97E4-C165E1A3758DQ38059750-A9EB35FD-FD47-4D6C-82E1-CE654D99FF01Q38560128-0E0F1CDD-45D2-4798-82D5-B4131BA83B40Q39247939-21482C9E-BC8B-40D7-9128-07761F813260Q39372910-76F7490E-297D-41FF-9950-DB7FA1ED2B4DQ40664549-20876F6A-CEC8-4861-9F92-A3B3E067DCBBQ43952848-0254FC57-19C6-48EB-AF7D-DDC54B3A022EQ57163790-577F63DB-D3F0-4AD3-9E20-4B1DDB701612
P2860
A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
A population-based clinical tr ...... malaria vaccine in Venezuela.
@en
A population-based clinical tr ...... malaria vaccine in Venezuela.
@nl
type
label
A population-based clinical tr ...... malaria vaccine in Venezuela.
@en
A population-based clinical tr ...... malaria vaccine in Venezuela.
@nl
prefLabel
A population-based clinical tr ...... malaria vaccine in Venezuela.
@en
A population-based clinical tr ...... malaria vaccine in Venezuela.
@nl
P2093
P356
P1476
A population-based clinical tr ...... malaria vaccine in Venezuela.
@en
P2093
Alarcón de Noya B
Gabaldón Berti Y
Jimenéz MA
P304
P356
10.1093/INFDIS/170.2.396
P407
P577
1994-08-01T00:00:00Z